Laboratory of Immunopharmacology and Experimental Therapeutics, Division of Cancer Research, Regional Cancer Centre, Medical College Campus, Thiruvananthapuram 695011, Kerala, India.
Laboratory of Immunopharmacology and Experimental Therapeutics, Division of Cancer Research, Regional Cancer Centre, Medical College Campus, Thiruvananthapuram 695011, Kerala, India.
Crit Rev Oncol Hematol. 2018 Feb;122:98-122. doi: 10.1016/j.critrevonc.2017.12.006. Epub 2017 Dec 24.
Mucins are the main structural components of mucus that create a selective protective barrier for epithelial surface and also execute wide range of other physiological functions. Mucins can be classified into two types, namely secreted mucins and membrane bounded mucins. Alterations in mucin expression or glycosylation and mislocalization have been seen in various types of pathological conditions such as cancers, inflammatory bowel disease and ocular disease, which highlight the importance of mucin in maintaining homeostasis. Hence mucins can be used as attractive target for therapeutic intervention. In this review, we discuss in detail about the structural diversity of mucins; their biosynthesis; its role in pathogenesis; regulation and as possible therapeutic targets.
黏蛋白是黏液的主要结构成分,为上皮表面形成选择性保护屏障,同时还执行多种其他生理功能。黏蛋白可分为分泌型黏蛋白和膜结合型黏蛋白。在各种病理状况下,如癌症、炎症性肠病和眼部疾病中,黏蛋白的表达或糖基化改变以及定位错误的现象很常见,这突出表明黏蛋白在维持体内平衡方面的重要性。因此,黏蛋白可以作为治疗干预的有吸引力的靶标。在这篇综述中,我们详细讨论了黏蛋白的结构多样性;它们的生物合成;在发病机制中的作用;调控以及作为可能的治疗靶标。